Tranexamic acid for trauma in the USA: is prejudice a barrier to saving lives? (2022)
Attributed to:
The CRASH-3 Trial: Tranexamic acid for the treatment of significant traumatic brain injury.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s0140-6736(22)00664-x
PubMed Identifier: 35429441
Publication URI: http://europepmc.org/abstract/MED/35429441
Type: Journal Article/Review
Volume: 399
Parent Publication: Lancet (London, England)
Issue: 10336
ISSN: 0140-6736